Skip to main content

Advertisement

SpringerLink
Log in

In response to “outcomes of patients with inflammatory breast cancer treated by breast conserving surgery”: the argument against breast conservation and sentinel lymph node biopsy in IBC

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

A Rebuttal Letter to this article was published on 11 July 2017

The Original Article was published on 18 October 2016

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Brzezinska M, Williams LJ, Thomas J et al (2016) Outcomes of patients with inflammatory breast cancer treated by breast-conserving surgery. Breast Cancer Res Treat 160(3):387–391 Epub 2016 Oct 18

    Article  CAS  Google Scholar 

  2. Goldner B, Behrendt CE, Schoellhammer HF et al (2014) Incidence of inflammatory breast cancer in women, 1992-2009, United States. Ann Surg Oncol. 21(4):1267–1270. doi:10.1245/s10434-013-3439-y

    Article  PubMed  Google Scholar 

  3. Dawood S, Merajver SD, Viens P et al (2011) International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol 22(3):515–523. doi:10.1093/annonc/mdq345 Epub 2010 Jul 5

    Article  CAS  PubMed  Google Scholar 

  4. Cardoso F, Costa A, Norton L et al (2014) ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)dagger. Ann Oncol 25(10):1871–1888. doi:10.1093/annonc/mdu385 Epub 2014 Sep 18

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Rea D, Francis A, Hanby AM et al (2015) Inflammatory breast cancer: time to standardise diagnosis assessment and management, and for the joining of forces to facilitate effective research. Br J Cancer 112(9):1613–1615. doi:10.1038/bjc.2015.115 Epub 2015 Mar 31

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Fisher B, Brown A, Mamounas E et al (1997) Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15(7):2483–2493

    Article  CAS  Google Scholar 

  7. Shen J, Valero V, Buchholz TA et al (2004) Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy. Ann Surg Oncol 11(9):854–860 Epub 2004 Aug 16

    Article  Google Scholar 

  8. Anscher MS, Jones P, Prosnitz LR et al (1993) Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg 218(1):22–28

    Article  CAS  Google Scholar 

  9. Huang EH, Tucker SL, Strom EA et al (2005) Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys 62(2):351–357

    Article  Google Scholar 

  10. Mamounas EP, Anderson SJ, Dignam JJ et al (2012) Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. J Clin Oncol 30(32):3960–3966. doi:10.1200/JCO.2011.40.8369 Epub 2012 Oct 1

    Article  PubMed  PubMed Central  Google Scholar 

  11. Jaffre F, Lavoue V, Mesbah H et al (2009) Prognosis for isolated skin recurrence after breast cancer treated by mastectomy. Anticancer Res 29(5):1697–1701

    PubMed  Google Scholar 

  12. Boughey JC, Suman VJ, Mittendorf EA et al (2013) Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA 310(14):1455–1461. doi:10.1001/jama.2013.278932

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Stearns V, Ewing CA, Slack R et al (2002) Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 9(3):235–242

    Article  Google Scholar 

  14. Hidar S, Bibi M, Gharbi O et al (2009) Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer. Int J Surg 7(3):272–275. doi:10.1016/j.ijsu.2009.04.012 Epub 2009 May 3

    Article  PubMed  Google Scholar 

  15. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (version 2.2017). www.nccn.org. Accessed 15 Jan 2017

  16. Boussen H, Cristofanilli M, Zaks T et al (2010) Phase II study to evaluate the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer. J Clin Oncol 28(20):3248–3255. doi:10.1200/JCO.2009.21.8594 Epub 2010 Jun 7

    Article  CAS  PubMed  Google Scholar 

  17. Cristofanilli M, Gonzalez-Angulo AM, Buzdar AU et al (2004) Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experience. Clin Breast Cancer 4(6):415–419

    Article  CAS  Google Scholar 

  18. Gianni L, Eiermann W, Semiglazov V et al (2014) Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort. Lancet Oncol 15(6):640–647. doi:10.1016/S1470-2045(14)70080-4

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Kelly J. Rosso & Anthony Lucci

  2. Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Naoto T. Ueno

  3. Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Wendy A. Woodward

  4. Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Naoto T. Ueno, Wendy A. Woodward & Anthony Lucci

  5. Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, 1400 Pressler Drive, Unit 1434, FCT7.5046, Houston, TX, 77030, USA

    Anthony Lucci

Authors
  1. Kelly J. Rosso
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naoto T. Ueno
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wendy A. Woodward
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anthony Lucci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anthony Lucci.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

This letter to the editor refers to the article available at doi:10.1007/s10549-016-4017-3 and a rebuttal letter to this letter to the editor is available at doi:10.1007/s10549-017-4368-4.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rosso, K.J., Ueno, N.T., Woodward, W.A. et al. In response to “outcomes of patients with inflammatory breast cancer treated by breast conserving surgery”: the argument against breast conservation and sentinel lymph node biopsy in IBC. Breast Cancer Res Treat 165, 779–781 (2017). https://doi.org/10.1007/s10549-017-4337-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-017-4337-y

Search

Navigation